Partial identification of a peptide from Lacticaseibacillus casei using MALDI TOF and it’s cytotoxic activity against MDA-MB-231 cell line

Jannatul Firdous Siddique Mohanasrinivasan Vaithilingam   

Open Access   

Published:  Jan 05, 2022


The current study focused to extract and purify the peptide of interest efficaciously from Lacticaseibacillus casei. The peptide of interest was partially identified and checked for anti-cancer activity using MDA-MB-231 triple negative breast cancer cell line. To begin with, it was purified via ammonium sulfate precipitation, ultrafiltration, and gel filtration chromatography. It was partially identified using mass matrix assisted laser desorption/ ionization-mass spectrometry (MS-MALDI) and checked for cytotoxic activity using (3-(4,5-Dimethylthiazol2-yl)-2,5-Diphenyltetrazolium Bromide) assay. As an outcome, the active part collected after ultra-filtration, 880 μg/ml of protein content with 15 mm zone diameter, was loaded on sephadexG50 column. The purified protein content was found to be 118 μg/ml with 15 mm of zone of inhibition against Listeria monocytogenes. A peak was obtained at a retention time of 9.371 minutes on subjected to high performance liquid chromatography. The result of MS-MALDI revealed it as an unnamed peptide with 75% query sequence similarity with the hypothetical protein of Lactobacillus reuteri. The cytotoxic study revealed its potential as an anti-cancer peptide, with the IC50 value of 108 μg/ml for MDA-MB-231 cancer cell line. In conclusion, this is the first report of this unknown peptide which showed both antibacterial and cytotoxic activity. It may act as a promising agent and can be further explored in future.

Keyword:     Chromatography RP-HPLC FT IR MS-MALDI cytotoxic


Siddique JF, Vaithilingam M. Partial identification of a peptide from Lacticaseibacillus casei using MALDI TOF and it’s cytotoxic activity against MDA-MB-231 cell line. J Appl Biol Biotech, Online First.

Copyright: Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license.

HTML Full Text


1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers CG, et al. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. World Health Organization, Geneva, Switzerland, 2012.

2. Raguz S, Yagüe E. Resistance to chemotherapy: new treatments and novel insights into an old problem. Br J Cancer 2008;99(3):387-91.

3. Jenssen H, Hamill P, Hancock RE. Peptide antimicrobial agents. Clin Microbiol Rev 2006;19(3):491-511.

4. Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS, Bulaj G, et al. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep 2013;30(1):108-60.

5. Cotter PD, Ross RP, Hill C. Bacteriocins-a viable alternative to antibiotics. Nat Rev Microbiol 2013;11(2):95-105.

6. Kaur S, Kaur S. Bacteriocins as potential anticancer agents. Front Pharmacol 2015;6:272.

7. Riedl S, Rinner B, Asslaber M, Schaider H, Walzer S, Novak A, et al. In search of a novel target-phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy. Biochim Biophys Acta Biomembranes 2011;1808(11):2638-45.

8. Farkas-Himsley H, Cheung R. Bacterial proteinaceous products (bacteriocins) as cytotoxic agents of neoplasia. Cancer Res 1976;36(10):3561-7.

9. Cornut G, Fortin C, Soulières D. Antineoplastic properties of bacteriocins: revisiting potential active agents. Am J Clin. Oncol 2008;31(4):399-404.

10. Singh PK, Sharma V, Patil PB, Korpole S. Identification, purification and characterization of laterosporulin, a novel bacteriocin produced by Brevibacillus sp. strain GI-9. PloS One 2012;7(3):e31498.

11. Baindara P, Gautam A, Raghava GP, Korpole S. Anticancer properties of a defensin like class IId bacteriocin Laterosporulin10. Sci Rep 2017;7(1):1-9.

12. Saito H, Watanabe T, Tomioka H. Purification, properties, and cytotoxic effect of a bacteriocin from Mycobacterium smegmatis. Antimicrob Agents Chemother 1979;15(4):504-9.

13. De Giani A, Bovio F, Forcella M, Fusi P, Sello G, Di Gennaro P. Identification of a bacteriocin-like compound from Lactobacillus plantarum with antimicrobial activity and effects on normal and cancerogenic human intestinal cells. AMB Express 2019;9(1):1.

14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 1983;65:55-63.

15. Sharma G, Dang S, Gupta S, Gabrani R. Antibacterial activity, cytotoxicity, and the mechanism of action of bacteriocin from Bacillus subtilis GAS101. Med Princ Pract 2018;27(2):186-92.

16. Slater T, Sawyer B, Sträuli U. Studies on succinate-tetrazolium reductase systems: III. Points of coupling of four different tetrazolium salts III. Points of coupling of four different tetrazolium salts. Biochem Biophys Acta 1963;77:383.

17. Zheng J, Wittouck S, Salvetti E, Franz CM, Harris H, Mattarelli P, et al. A taxonomic note on the genus Lactobacillus: description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. Int J Syst Evol Microbiol 2020;70(4):2782-858.

18. Daw MA, Falkiner FR. Bacteriocins: nature, function and structure. Micron 1996;27(6):467-79.

19. Sabo SS, Converti A, Ichiwaki S, Oliveira RP. Bacteriocin production by Lactobacillus plantarum ST16Pa in supplemented whey powder formulations. J Dairy Sci 2019;102(1):87-99.

20. Ajesh K, Sudarslal S, Arunan C, Sreejith K. Kannurin, a novel lipopeptide from Bacillus cereus strain AK 1: isolation, structural evaluation and antifungal activities. J Appl Microbiol 2013;115(6):1287-96.

21. Coates J. Interpretation of infrared spectra, a practical approach. In: Encyclopedia of analytical chemistry: applications, theory and instrumentation. John Wiley & Sons, Ltd; Newtown, CT, 2006.

22. Zhang J, Yang Y, Yang H, Bu Y, Yi H, Zhang L, et al. Purification and partial characterization of bacteriocin Lac-B23, a novel bacteriocin production by Lactobacillus plantarum J23, isolated from Chinese traditional fermented milk. Front Microbiol 2018;9:2165.

23. Pilco-Ferreto N, Calaf GM. Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines. Int J Oncol 2016;49(2):753-62.

Article Metrics

3 Absract views 0 PDF Downloads 3 Total views

Related Search

By author names

    Warning: Cannot modify header information - headers already sent by (output started at /home/jabonlin/public_html/jab_php/abstract.php:242) in /home/jabonlin/public_html/jab_php/articlemodule/searchArticles.php on line 1162

    Warning: Invalid argument supplied for foreach() in /home/jabonlin/public_html/jab_php/abstract.php on line 819

Citiaion Alert By Google Scholar

Name Required
Email Required Invalid Email Address

Comment required

Notice: Undefined variable: dbq35 in /home/jabonlin/public_html/jab_php/abstract.php on line 942

Warning: mysqli_num_rows() expects parameter 1 to be mysqli_result, null given in /home/jabonlin/public_html/jab_php/articlemodule/database.php on line 379
Similar Articles